Ichimasu Norio, Kohno Michihiro, Nakajima Nobuyuki, Matsunaga Kyosuke, Matsushima Ken, Tsukahara Kiyoaki
Department of Neurosurgery, Hachioji Medical Center, Tokyo Medical University, Hachioji, Tokyo, Japan.
Department of Neurosurgery, Tokyo Medical University, 6-7-1, Nishi-Shinjuku, Shinjuku-Ku, Tokyo, 160-0023, Japan.
Acta Neurochir (Wien). 2025 Jul 14;167(1):191. doi: 10.1007/s00701-025-06507-6.
In our previous study on vestibular schwannomas (VSs), we found that preserved useful hearing function in patients immediately after surgery gradually deteriorated in long-term period, and was lost in 13% of patients 5 years after surgery. In this retrospective study, we aimed to investigate the long-term hearing prognosis of patients with cerebellopontine angle (CPA) tumors other than VSs, and clarify whether the phenomenon of hearing deterioration after surgery occurs only in patients with VSs.
Patient backgrounds and otologic data were investigated in 70 patients (meningioma: 37; trigeminal schwannoma: 9; facial nerve schwannoma: 4; jugular foramen schwannoma: 9; and epidermoid cysts: 11) with preserved useful hearing function after surgery (American Academy of Otolaryngology-Head and Neck Surgery classification Class A or B).
Of the 70 patients (average age: 44 years; tumor diameter: 35 mm; resection rate: 96%; follow-up period: 62 months; 61 patients in Class A and 9 patients in Class B immediately after surgery), 60 patients (86%) had unchanged, 5 patients (7%) had improved, and 5 patients (7%) had worsened hearing class during the follow-up period. Only 1 patient (facial nerve schwannoma) experienced a change from Class B to C, and was out of useful-hearing range at the final follow-up (the useful hearing preservation rate: 99%). Distortion product otoacoustic emissions (DPOAEs) reflecting inner ear function were detected in 61 patients (87%) at the final follow-up, and only 4 patients (6%) demonstrated a worsening of DPOAEs during the postoperative follow-up period.
Useful hearing function after surgery was preserved at a high rate during a long-term postoperative period in patients with typical CPA tumors other than VSs. Compared with patients with VSs, in whom hearing loss owing to inner ear dysfunction is not rare in the long-term after surgery, patients with CPA tumors demonstrated a apparently lower incidence of inner ear dysfunction and a more favorable long-term hearing prognosis. In patients with CPA tumors, not only hearing improvement by the surgery but also its long-term preservation can be expected. In this study, we confirmed that the phenomenon of postoperative hearing deterioration occurs only in patients with VSs among all CPA tumors.
在我们之前关于前庭神经鞘瘤(VS)的研究中,我们发现患者术后立即保留的有用听力功能在长期内逐渐恶化,并且在术后5年有13%的患者听力丧失。在这项回顾性研究中,我们旨在调查除VS外的桥小脑角(CPA)肿瘤患者的长期听力预后,并阐明术后听力恶化现象是否仅发生在VS患者中。
调查了70例术后保留有用听力功能的患者(脑膜瘤:37例;三叉神经鞘瘤:9例;面神经鞘瘤:4例;颈静脉孔神经鞘瘤:9例;表皮样囊肿:11例)的患者背景和耳科数据(美国耳鼻咽喉头颈外科学会分类A或B级)。
70例患者(平均年龄:44岁;肿瘤直径:35mm;切除率:96%;随访期:62个月;术后立即61例为A级,9例为B级)中,60例(86%)听力分级无变化,5例(7%)听力改善,5例(7%)听力恶化。只有1例患者(面神经鞘瘤)从B级变为C级,在最后一次随访时超出了有用听力范围(有用听力保留率:99%)。在最后一次随访时,61例患者(87%)检测到反映内耳功能的畸变产物耳声发射(DPOAE),术后随访期间只有4例患者(6%)的DPOAE恶化。
除VS外的典型CPA肿瘤患者术后有用听力功能在术后长期内保持较高的保留率。与VS患者相比,VS患者术后长期因内耳功能障碍导致听力丧失并不少见,CPA肿瘤患者内耳功能障碍的发生率明显较低,长期听力预后更有利。对于CPA肿瘤患者,不仅手术可改善听力,而且可预期长期保留听力。在本研究中,我们证实了术后听力恶化现象仅发生在所有CPA肿瘤中的VS患者中。